A61K - Cooperative Patent Classification
A61K - Cooperative Patent Classification
A61K - Cooperative Patent Classification
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
CPC - <strong>A61K</strong> - 2013.07 - page 32<br />
<strong>A61K</strong> 33/22 . Boron compounds<br />
<strong>A61K</strong> 33/24 . Heavy metals ; Compounds thereof<br />
<strong>A61K</strong> 33/245 . . { Bismuth; Derivatives thereof }<br />
<strong>A61K</strong> 33/26 . . Iron ; Compounds thereof<br />
<strong>A61K</strong> 33/28 . . Mercury ; Compounds thereof<br />
<strong>A61K</strong> 33/30 . . Zinc ; Compounds thereof<br />
<strong>A61K</strong> 33/32 . . Manganese ; Compounds thereof<br />
<strong>A61K</strong> 33/34 . . Copper ; Compounds thereof<br />
<strong>A61K</strong> 33/36 . . Arsenic ; Compounds thereof<br />
<strong>A61K</strong> 33/38 . . Silver ; Compounds thereof<br />
<strong>A61K</strong> 33/40 . Peroxides<br />
<strong>A61K</strong> 33/42 . Phosphorus ; Compounds thereof<br />
<strong>A61K</strong> 33/44 . Elemental carbon, e.g. charcoal, carbon black<br />
<strong>A61K</strong> 35/00<br />
Medicinal preparations containing materials or reaction products thereof with<br />
undetermined constitution<br />
NOTE<br />
-<br />
When classifying in this group, the last place rule (applied throughout <strong>A61K</strong> ) does<br />
not apply. Namely, classification is made for each active component or material.<br />
WARNING<br />
-<br />
Groups <strong>A61K</strong> 35/13 , <strong>A61K</strong> 35/15 , <strong>A61K</strong> 35/17 , <strong>A61K</strong> 35/19 , <strong>A61K</strong> 35/33 , <strong>A61K</strong><br />
35/35 , <strong>A61K</strong> 35/51 , <strong>A61K</strong> 35/57 , <strong>A61K</strong> 35/61 do not correspond to former or<br />
future IPC. Concordance CPC : IPC for these groups is as follows: - <strong>A61K</strong> 35/13 :<br />
<strong>A61K</strong> 35/12 - <strong>A61K</strong> 35/15 : <strong>A61K</strong> 35/14 - <strong>A61K</strong> 35/17 : <strong>A61K</strong> 35/14 - <strong>A61K</strong> 35/19 :<br />
<strong>A61K</strong> 35/14 - <strong>A61K</strong> 35/33 : <strong>A61K</strong> 35/12 - <strong>A61K</strong> 35/35 : <strong>A61K</strong> 35/12 - <strong>A61K</strong> 35/51 :<br />
<strong>A61K</strong> 35/48 - <strong>A61K</strong> 35/57 : <strong>A61K</strong> 35/56 - <strong>A61K</strong> 35/61 : <strong>A61K</strong> 35/56<br />
<strong>A61K</strong> 35/02 . from inanimate materials<br />
<strong>A61K</strong> 35/04 . . Tars ; Bitumens ; Mineral oils ; Ammonium bituminisulfonates, e.g. ichthyol (<br />
carbon <strong>A61K</strong> 33/00 )<br />
<strong>A61K</strong> 35/06 . . . Mineral oils, { e.g. paraffinic oils, aromatic oils based on aromatic hydrocarbons<br />
( essential oils derived from plants <strong>A61K</strong> 36/00 ) }<br />
<strong>A61K</strong> 35/08 . . Mineral waters; { Sea water }<br />
<strong>A61K</strong> 35/10 . . Peat ; Amber; { Turf; Humus ( wood tar, sap or resin <strong>A61K</strong> 36/00 ) }<br />
<strong>A61K</strong> 35/12 . Materials from mammals; { compositions comprising non-specified tissues or cells;<br />
Compositions comprising non-embryonic stem cells ( uncharacterized stem cells <strong>A61K</strong><br />
35/545 ) ; Genetically modified cells ( gene therapy C12N 5/10 ; vaccines or medicinal<br />
preparations containing antigens or antibodies <strong>A61K</strong> 39/00 ) } { Note: If the cells are<br />
characterized, classify under the corresponding tissue or tissue of origin }